Amicus Therapeutics
FOLD
#3208
Rank
โ‚ฌ4.14 B
Marketcap
13,20ย โ‚ฌ
Share price
0.00%
Change (1 day)
103.60%
Change (1 year)

EPS for Amicus Therapeutics (FOLD)

EPS in 2025 (TTM): -0,09941ย โ‚ฌ

According to Amicus Therapeutics 's latest financial reports the company's current EPS (TTM) is -0,10ย โ‚ฌ. In 2014 the company made an earnings per share (EPS) of -0,85ย โ‚ฌ.

EPS history for Amicus Therapeutics from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-0,09941ย โ‚ฌ
2014-0,85ย โ‚ฌ
2012-0,99ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novo Nordisk
NVO
3,60ย โ‚ฌ-3,687.14%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Biogen
BIIB
2,15ย โ‚ฌ-2,245.45%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
2,62ย โ‚ฌ-2,715.77%๐Ÿ‡ฌ๐Ÿ‡ง UK
Lexicon Pharmaceuticals
LXRX
-0,13ย โ‚ฌ 27.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-0,01822ย โ‚ฌ-81.82%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
-0,08201ย โ‚ฌ-18.18%๐Ÿ‡บ๐Ÿ‡ธ USA